Australia’s Austin Health Selects ProVation® Medical Software for Gastroenterology Documentation and Coding

MINNEAPOLIS, MN – May 29, 2012 — Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Austin Health has selected its ProVation® Medical Software for gastroenterology procedure documentation and coding.

Located in Victoria, Australia, Austin Health is the major provider of tertiary health services, health professional education and research in northeast Melbourne. World-renowned for its research and specialist work in cancer, liver transplantation, spinal cord injuries, neurology, endocrinology, mental health and rehabilitation, it consists of Austin Hospital, Heidelberg Repatriation Hospital, the Royal Talbot Rehabilitation Centre and eight independent research institutions.

“Austin Health is a renowned center for excellence and outstanding leadership in healthcare, research and education,” said Mike Haldane, Vice President and General Manager, Clinical Documentation, Wolters Kluwer Health Clinical Solutions. “We are honored that ProVation MD for GI has been selected by this prestigious institution to provide streamlined documentation and coding in its GI labs.”

About ProVation Medical

ProVation^® Medical provides procedure documentation and clinical decision support solutions for hospitals and Ambulatory Surgery Centers. ProVation MD, ProVation MultiCaregiver and ProVation EHR software reduce transcription, paper storage and image printing costs and deliver a high Return on Investment (ROI). ProVation^® Order Sets, powered by UpToDate Decision Support, puts evidence-based healthcare into practice by establishing and maintaining standards of care.

ProVation^® Medical is part of Wolters Kluwer Health, a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company with 2011 annual revenues of €3.4 billion ($4.7 billion).